Perivan add a further 10 inaugural Annual Report clients to its growing portfolio in April
May 2022
Following the recent high volume of IPO activity, where Perivan has been firmly established as the UK leader in the production of admission documents with a 42% overall market share in 2021, the shareholder communications team is proud to have been selected to help a further 10 newly listed companies in April with the production of their inaugural Annual Reports at this important stage of their corporate journey.
“Received the accounts today and thanks for the care and attention over the last few weeks. You’ve smashed the art of client care – making the smallest account feel like they’re the biggest”.
David Anderson, Chief Financial Officer at LungLife
Perivan specialise in the production and publication of financial documents relating to shareholder and investor communications for quoted companies, private companies and open and closed-ended funds.